If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Position
Professor of Medicinal Chemistry
Scientific Director Monash Fragment-Based Drug Design Platform

Medicinal Chemistry
Monash Institute of Pharmaceutical Sciences

Research interests

Fragment-based drug design
Structure-based design of novel anti-microbial agents
Analysis of protein-ligand interactions
Protein structure determination and structural biology

Monash teaching commitment

  • Spectrometric identification of small molecules
  • Drug-protein interactions

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2001 2020

Research Output 1994 2018

Fatty Acid-Binding Protein 5 Mediates the Uptake of Fatty Acids, but not Drugs, Into Human Brain Endothelial Cells

Lee, G. S., Pan, Y., Scanlon, M. J., Porter, C. J. H. & Nicolazzo, J. A. 2018 (Accepted/In press) In : Journal of Pharmaceutical Sciences. 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1

Mohanty, B., Rimmer, K., McMahon, R. M., Headey, S. J., Vazirani, M., Shouldice, S. R., Coinçon, M., Tay, S., Morton, C. J., Simpson, J. S., Martin, J. L. & Scanlon, M. J. 1 Mar 2017 In : PLoS ONE. 12, 3, 20 p., e0173436

Research output: Contribution to journalArticleResearchpeer-review

File

HN, N, Cα and Cβ assignments of the two periplasmic domains of Neisseria meningitidis DsbD

Smith, R. P., Mohanty, B., Williams, M. L., Scanlon, M. J. & Heras, B. 2017 (Accepted/In press) In : Biomolecular NMR Assignments. 6 p.

Research output: Contribution to journalArticleResearchpeer-review

Activities 2013 2013

  • 1 Submissions to industry or govt committees, commissions and inquiries

Medicinal Chemistry

Scanlon, M. (Member)
2 Sep 2013

Activity: Submissions to industry or govt committees, commissions and inquiries